ST2: a novel remodeling biomarker in acute and chronic heart failure (Q28280799)

Current heart failure reports

Europe PubMed Central

title

ST2: a novel remodeling biomarker in acute and chronic heart failure (English)

0 references

main subject

biomarker

0 references

heart failure

0 references

chronic heart failure

1 reference

2

James L Januzzi

0 references

Ravi V Shah

series ordinal

1

object named as

Ravi V Shah

0 references

language of work or name

English

0 references

publication date

March 2010

0 references

published in

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-010-0005-9

volume

7

0 references

issue

1

0 references

page(s)

9-14

0 references

exact match

0 references

cites work

NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy.

1 reference

12 December 2020

Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea

1 reference

12 December 2020

Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load

1 reference

12 December 2020

1 reference

12 December 2020

Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure

1 reference

12 December 2020

Identification of serum soluble ST2 receptor as a novel heart failure biomarker

1 reference

12 December 2020

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction

1 reference

12 December 2020

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

1 reference

12 December 2020

Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.

1 reference

12 December 2020

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

1 reference

12 December 2020

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

1 reference

12 December 2020

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

1 reference

12 December 2020

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

1 reference

12 December 2020

Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay

1 reference

12 December 2020

N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction.

1 reference

12 December 2020

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

1 reference

12 December 2020

Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells

1 reference

12 December 2020

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

1 reference

12 December 2020

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

1 reference

12 December 2020

Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism

1 reference

12 December 2020

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

1 reference

12 December 2020

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

12 December 2020

Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling

1 reference

12 December 2020

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

1 reference

12 December 2020

Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure

1 reference

12 December 2020